Chronic Statin Therapy and Histologic Gastric Changes

1. Martinez AI, Freeman PR, Moga DC. Statin Use and Gastrointestinal Hemorrhage: A Large Retrospective Cohort Study. Am J Cardiovasc Drugs. 2018 Sep 26. doi: 10.1007/s40256-018-0301-4. [Epub ahead of print]10.1007/s40256-018-0301-4.[EpubaheadprintOpen DOISearch in Google Scholar

2. Smith I, Schmidt R, Halm EA, Mansi IA. Do Statins Increase the Risk of Esophageal Conditions? Findings from Four Propensity Score-Matched Analyses. Clin Drug Investig. 2018;38:135-146.10.1007/s40261-017-0589-xSearch in Google Scholar

3. Kuoppala J, Lamminpaa A, Pukkala E. Statins and cancer: A systematic review and meta-analysis. Eur J Cancer. 2008;44:2122-2132.10.1016/j.ejca.2008.06.025Search in Google Scholar

4. Browning DR, Martin RM. Statins and the risk of cancer: A systematic review and metanalysis. Int J Cancer. 2007;120:833-843.10.1002/ijc.22366Search in Google Scholar

5. Badillo R, Schmidt R, Mortensen EM, Frei CR, Mansi I. Statin therapy and gastrointestinal hemorrhage: a retrospective cohort study with propensity score-matching. Pharmacoepidemiol Drug Saf. 2015;24:849-857.10.1002/pds.3817Search in Google Scholar

6. Joo MK, Park JJ, Chun HJ. Additional Benefits of Routine Drugs on Gastrointestinal Cancer: Statins, Metformin, and Proton Pump Inhibitors. Dig Dis. 2018;36:1-14.10.1159/000480149Search in Google Scholar

7. Negovan A, Iancu M, Moldovan V, et al. The contribution of clinical and pathological predisposing factors to severe gastro-duodenal lesions in patients with low dose aspirin and proton pump inhibitor therapy. Eur J Intern Med. 2017;44:62-66.10.1016/j.ejim.2017.05.017Search in Google Scholar

8. Park YH, Kim N. Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer. J Cancer Prev. 2015;20:25-40.10.15430/JCP.2015.20.1.25Search in Google Scholar

9. Cheung KS, Leung WK. Risk of gastric cancer development after eradication of Helicobacter pylori. World J Gastrointest Oncol. 2018;10:115-123.10.4251/wjgo.v10.i5.115Search in Google Scholar

10. Cheung KS, Chan EW, Wong AY, Chen L, Wong ICK, Leung WK. Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population based study. Gut. 2018;67:28-35.10.1136/gutjnl-2017-314605Search in Google Scholar

11. Yoom H, Kim N. Diagnosis and management of high risk group for gastric cancer. Gut Liver. 2015;9:5-17.10.5009/gnl14118Search in Google Scholar

12. Wang WH, Huang JQ, Zheng GF, Lam SK, Karlberg J, Wong BC. Nonsteroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis. J Natl Cancer Inst. 2003;95:1784-1791.10.1093/jnci/djg106Search in Google Scholar

13. Algra AM, Rothwell PM. Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomized trials. Lancet Oncol. 2012;13:518-527.10.1016/S1470-2045(12)70112-2Search in Google Scholar

14. Emberson JR, Kearny PM, Blackwell L, et al. Cholesterol Treatment Trialists’ (CTT) Collaboration. Lack of effect of lowering LDL cholesterol on cancer. Meta-analysis of individual data from 175.000 people in 27 randomized trials of statin therapy. PLoS One. 2012;7:e29849.10.1371/journal.pone.0029849326184622276132Search in Google Scholar

15. Shimoyama S. Statins and gastric cancer risk. Hepatology. 2011;58:1057-1061.Search in Google Scholar

16. Chiu HF, Ho SC, Chang CC, Wu TN, Yang CY. Statins are associated with a reduced risk of gastric cancer: A population-based case-control study. Am J Gastroenterol. 2011;106:2098-2103.10.1038/ajg.2011.27721844922Search in Google Scholar

17. Leung HW, Chan AL, Lo D, Leung JH, Chen HL. Common cancer risk and statins: A population-based case-control study in a Chinese population. Expert Opinion on Drug Safety. 2013;12:19-27.10.1517/14740338.2013.74439223199231Search in Google Scholar

18. Ma Z, Wang W, Jin G, Chu P, Li H. Effect of statins on gastric cancer incidence: a meta-analysis of case control studies. J Cancer Res Ther. 2014;10:859-865.10.4103/0973-1482.13821825579519Search in Google Scholar

19. Negovan A, Iancu M, Moldovan V, Mocan S, Banescu C. The Interaction between GSTT1, GSTM1, and GSTP1 Ile105Val Gene Polymorphisms and Environmental Risk Factors in Premalignant Gastric Lesions Risk. Biomed Res Int. 2017;2017:7365080.10.1155/2017/7365080527468028182092Search in Google Scholar